Fe/sub 78/B/sub 13/Si/sub 9/
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... characterization, Fe m O n -SiO 2 composite flake-like and SiO 2 -Fe m O n core-shell IONPs demonstrated spherical shape with mean diameter of 98 ± 22 and 101 ± 19 nm, respectively (Figure ...2B–E). ...
11
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... All univariate statistical tests were two-sided, and sig- nificance was set at P,0.05. Multivariate statistical analysis can take internal relationships and mutual influence among variables into account; therefore, the ...
16
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... to Fe 3 O 4 NPs (100 µ g/mL), there was a progressive decrease in the activity of MEP-induced channels, which occurred at the level of hyperpolarizing potentials ranging between − 80 and − 200 ...of Fe 3 O ...
10
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... Transmission electron microscopy of the magnetic iron oxide nanoparticles and iron oxide nanoparticles coated with chitosan and gallic acid was performed to determine the shape, size, and uniformity of the particles ...
12
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... from healthy Sprague Dawley rats was collected in heparin- coated tubes. The red blood cells (RBCs) were obtained by centrifugation at 1,500 rpm for 5 minutes, and the upper plasma was removed. The RBCs were then washed ...
13
Preparation and in vitro evaluation of doxorubicin-loaded Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles modified with biocompatible copolymers
... that Fe 3 O 4 -PLGA-PEG 2000 -doxorubicin has dose-dependent and time-dependent cytotoxicity against the A549 lung can- cer cell line (IC 50 ...that Fe 3 O 4 -PLGA-PEG 3000 -doxorubicin has dose- dependent ...
16
Fe<sub>3</sub>O<sub>4</sub>/Au magnetic nanoparticle amplification strategies for ultrasensitive electrochemical immunoassay of alfa-fetoprotein
... the Fe 3 O 4 /Au nanocarrier, the ratio of HRP and Ab 2 is the most important factor in the response ...per Fe 3 O 4 /Au nanocarrier, which would be expected to increase the response amplification for this ...
11
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... average weights of the three TiO 2 NP groups and three Fe 3 O 4 - TiO 2 NP groups were 399.16 ± 13.56 g, 401.50 ± 16.48 g, 409.80 ± 26.60 g, 427.83 ± 23.16 g, 396.71 ± 27.86 g, and 413.80 ± 25.74 g, respectively. ...
15
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... of Fe 3 O 4 nano magnetofluid (0.5, 1.0, 1.5, and 2.0 g/L Fe 3 O 4 ), and a simple magnetic field irradiation group (a negative control group plus magnetic field ...
10
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... ± 9 µ g/g and 211 ± 18 µ g/g, respectively, on day 3 after ...of Fe 3 O 4 MNPs were higher in the liver and spleen than those in other ...for Fe 3 O 4 ...
6
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... of Fe 3 O 4 ...experimental Fe 3 O 4 -MNPs/DNR groups and negative controls (P ...the Fe 3 O 4 -MNPs/DNR was ...experimental Fe 3 O 4 -MNPs/ DNR groups were ...Self-assembled Fe 3 O 4 ...
6
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
... for NH 2 OH 3 HCl and HAuCl 4 ) were performed during the reaction, and the stirring continued for at least 30 minutes after each addition. The clear black solution became brown at first addition and changed to garnet ...
15
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... of Fe 3 O 4 , Dex/Fe 3 O 4 , and Bis/Dex/Fe 3 O 4 was verified by XRD (Figure ...standard Fe 3 O 4 pattern published by ...Bis/Dex/ Fe 3 O 4 was smaller than that of Fe 3 O 4 ...
12
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... nanoprobe Fe 3 O 4 @SiO 2 modified with anti-mesothelin antibody (A-MFS) was prepared to target cells and tumor tissues highly expressing mesothelin in vitro (human pancreatic cancer cell line SW1990) and in vivo ...
13
Vancomycin-modified Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Ag microflowers as effective antimicrobial agents
... Van/ Fe 3 O 4 @SiO 2 @Ag microflowers decreased by ∼ 60% for ...only Fe 3 O 4 @SiO 2 @Ag ...vancomycin-modified Fe 3 O 4 @SiO 2 @Ag microflowers against resistant strains such as MRSA pro- vides a ...
18
The changes of T lymphocytes and cytokines in ICR mice fed with Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... cells/mL with RPMI-1640. The adjusted cells were placed in a 96-well microtiter plate in 200 µ L aliquots and cultured in the presence of T-lymphocytes mitogen (5 µ g/mL Con- canavalin A [ConA]) (Sigma Chemical Co, St. ...
6
Multifunctional magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
... the Fe 3 O 4 -MNP-DNR-5-BrTet and Fe 3 O 4 -MNP groups; karyopyknosis and karyorrhexis could be observed in the apoptotic cells, especially in the Fe 3 O 4 -MNP-DNR-5-BrTet ...the Fe 3 O 4 - ...
9
Sub-barrier fusion of Si+Si systems
... Hindrance is a suppression of fusion cross section with respect to standard CC calculations, occurring far below the Coulomb barrier [12, 13]. The investigation of hindrance usually makes use of two ...
5
Synergistic effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> with gambogic acid on apoptosis of K562 leukemia cells
... to transmembrane protein TfR, but also permeated the cell membrane and distributed in the cell matrix. Apart from the “extrinsic” pathway, they hypothesized that the intrinsic mitochondrial pathway for the activation of ...
9
Ultrasmall superparamagnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles: honey-based green and facile synthesis and in vitro viability assay
... In the synthesis of Fe 3 O 4 -NPs, different amounts of natural honey 0.5, 1.0, 3.0 and 5.0 g were added to 100 mL of deion- ized water, as the coprecipitation agent and stabilizer to control the particle size. ...
9